| 释义 |
thrombolysis in myocardial infarction 1 ?心肌梗死溶栓试验 按术后即刻心肌梗死溶栓试验(Thrombolysis In Myocardial Infarction,TIMI)血流分级将病人分为2组:正常复流组(138例)和无复流组(52例),比较两组患者的基本临床资料、实验室检查结果及PCI术中靶病变及... 2 ?血流分级 与传统造模方法相比,评判造模前后的冠状动脉造影血流分级(Thrombolysis in Myocardial Infarction,TIMI)评分、管腔内径,血管内膜厚度和泡沫细胞阳性面积的变化,以及血凝血酶原时间(Prothrombin T... 3 ?心肌梗死溶栓治疗 结果:替罗非班组于术前应用盐酸替罗非班使PCI前梗死相关血管心肌梗死溶栓治疗(thrombolysis in myocardial infarction,TIMI)血流分级提高,替罗非班组达1级、2级血流者比例分别高于对照组(均P<0·01),对照组完全闭塞比率明...
- 1
Results of coronary angiography, clinical effect and thrombolysis in myocardial infarction trial (TIMI) of the two groups were compared and analyzed. 比较两组造影结果、临床预后及心肌梗塞溶栓(TIMI)血流分级。 - 2
Objective: To study the efficacy and safety with thrombolysis of urokinase produced in China on acute myocardial infarction. 目的：评价国产尿激酶在急性心肌梗死溶栓治疗中的有效性和安全性。 - 3
Objectives to investigate the clinical features in type 2 diabetic patients with acute myocardial infarction (AMI) and to assess the therapeutic effects of intravenous thrombolysis. 目的探讨2型糖尿病并发急性心肌梗死的临床特征与静脉溶栓的疗效。
|